Does Cleidocranial Dysplasia have a cure?

Currently, there is no medical cure for Cleidocranial Dysplasia (CCD), as it is a genetic condition caused by mutations in the RUNX2 gene that affect skeletal and dental development. While a cure does not exist, clinical management focuses on multidisciplinary interventions to address specific skeletal and dental symptoms, allowing individuals with Cleidocranial Dysplasia to lead full, active lives.

How is Cleidocranial Dysplasia managed today?

Treatment for Cleidocranial Dysplasia is primarily supportive and tailored to the individual's specific skeletal and dental needs. Because RUNX2 mutations impact bone formation, management often requires a team of specialists, including orthodontists, oral surgeons, and orthopedists. Common clinical approaches include:

• Dental intervention: Managing delayed eruption of permanent teeth through surgical exposure and orthodontic traction.


• Surgical correction: Procedures to address issues like hip dysplasia or scoliosis, which occur in a subset of patients.


• Monitoring: Regular oversight to manage bone density and potential developmental delays.

What does the future of research look like for Cleidocranial Dysplasia?

Researchers are currently focused on understanding the precise mechanisms of the RUNX2 pathway. While gene therapy for Cleidocranial Dysplasia is not yet in human clinical trials, precision medicine research is exploring how we might modulate bone signaling pathways. The goal of current research is to identify therapeutic targets that could potentially stimulate bone growth or enhance dental development in those affected by Cleidocranial Dysplasia.

Are there clinical trials available?

There are currently limited active clinical trials specifically focused on reversing the underlying genetic cause of Cleidocranial Dysplasia. Most clinical studies remain observational, aimed at better characterizing the natural history of Cleidocranial Dysplasia to prepare for future interventional trials. Patients are encouraged to monitor registries for updates on novel therapies targeting skeletal dysplasia.

Next steps

• Consult with a geneticist to confirm your diagnosis and understand the inheritance pattern of Cleidocranial Dysplasia.


• Connect with the 89 members of the DiseaseMaps.org community to share experiences and coping strategies.


• Register with the NIH GARD or the Cleidocranial Dysplasia Foundation to receive alerts regarding new research developments.

Medical disclaimer: This information is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment.

References

• NIH Genetic and Rare Diseases (GARD) Information Center: Cleidocranial Dysplasia.


• Orphanet: Rare disease database entry for Cleidocranial Dysplasia (ORPHA203).


• OMIM (Online Mendelian Inheritance in Man): Entry #119600 (Cleidocranial Dysplasia).


• Cleidocranial Dysplasia Foundation (ccdfoundation.org).